Intro to Clinical Oncology Flashcards

1
Q

Most common malignancies and most common causes of death

A

Most common malignancies:

  1. Prostate/breast
  2. Lung/Bronchus
  3. Colon

Most common causes of death

  1. Lung/bronchus
  2. Prostate/breast
  3. Colon
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How does cancer present?

A
  1. Local symptoms of disease:
    - Interference with normal organ function –> bowel obstruction, cough
    - Direct extension into adjacent organ/structures –> chest wall pain
  2. Symptoms of metastatic disease:
    - Pain or organ dysfunction from disease that has pread to other organs –> bone pain, seizures, headache
  3. Paraneoplast:
    - Abnormal hormone production
  4. Incidental or screening
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Presentations of hematologic malignancies

A
  1. Bone marrow failure
    - anemia –> weakness, fatigue, dyspnea
    - thrombocytopenia –> bleeding, bruising
    - leucopenia –> infection
  2. Bone marrow proliferation
    - erythrocytosis (PCRV) –> headache, plethora
    - thrombocytosis –> thrombosis, bleeding
    - leukocytosis –> dyspnea, confusion
    - splenomegaly
  3. Lymphadenopathy
  4. B-symptoms: fever, night sweats, weight loss
    - due to elaboration of cytokines
  5. Thrombosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Signs (physical findings) and symptoms (what the patient reports)

A

Local symptoms:

  • pain
  • mass
  • organ dysfunction –> symptoms depend on the organ
  • direct extension to adjacent organs –> e.g. difficulty swallowing due to a tumor in the bronchus obstructing the esophagus

Metastatic disease:

  • lumps, bumps
  • pain
  • symptoms referable to disruption of normal organ function –> obstruction, seizure, paralysis, fracture
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Paraneoplastic symptoms

A

Symptoms that result from various substances secreted by the tumor or as a response to the tumor –> not a direct effect of malignancy

  • weight loss without GI tract obstruction
  • hypercalcemia
  • hyponatremia
  • “clubbing”

DVT and pulmonary embolism = common presentation and/or complication due to hypercoagulability

  • requires immediate diagnosis and anticoagulation
  • potentially fatal

Clubbing

Cutaneous signs of malignancy –> can be direct extension, paraneoplastic or metastatic
- cutaneous metastases generally associated with poor prognosis

Cancer anorexia and cachexia –> weight loss is common (>10%)

  • frequent presenting sign
  • usually associated with advanced disease
  • etiology is controversial
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Difference between incidental finding and screening

A

Incidental = patient evaluated for another reason

  • frequently, an unsuspected radiologic finding
  • major source of medicolegal problems

Screening

  • recommended for breast, colon, cervical, lung in certain patients (sprial CT)
  • prostate (PSA blood test) is controversial
  • more complex than most appreciate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Screening for cancer

A

Detecting cancer before symptoms and signs

  • basic premise is that smaller/earlier is better –> proven to be true in some disease, but not in others
  • level of benefit varies –> best where the site of tumor is directly sampled (e.g. pap smear or colonoscopy); less effective when radiologic imaging is used (e.g. mammography or CT scan)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Current recommended screening for standard risk population

A
  • Breast cancer –> mammography after age 50
  • Colon cancer –> colonoscopy after age 50
  • Cervical cancer –> pap smears
  • Head and neck cancer –> evaluation during dental exam
  • Prostate cancer –> PSA testing in males >50 (controversial)
  • Lung cancer (as of 2011) –> low dose helical CT for patients with significant smoking history, >55, only at institutions with substantial expertise
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Diagnosis of cancer

A

There must be histologic or cytologic proof of disease –> rare exceptions

  • biopsy should be from the most accessible, least dangerous place –> generally, if you prove a cancer from a distant site, you do not need to biopsy the primary tumor unless curable approaches to both sites would be changed
  • the biopsy should come before the rest of the evaluation, however a certain degree of radiographic evaluation is frequently performed simultaneously

Example of biopsy dilemmas:
1 41 y.o female presents with a breast lump and a single bony swelling in the distal femur. Biopsy of breast = infiltrating ductal cancer
- should the leg also be biopsied? –> YES! if low grade chondrosarcoma, patient could have two ultimately curable neoplasms
2. 50 y.o. male smoker presents with pancytopenia and a lung mass apparent on chest x ray. Bone marrow biopsy = diagnostic of small cell lung cancer
- can proceed with tx for small cell lung cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

The diagnostic biopsy

A
  • need a diagnosis –> “suspicious” and “possible” are not good enough, need the definitive proof for diagnosis
  • need enough tissue to perform special stains and other analysis –> FNA usually not enough
  • immunohistochemistry –> can distinguish tissue of origin in difficult cases
  • molecular analysis –> for therapeutic decisions (Her2/neu, EGFR, k-ras, etc.)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Staging

- clinical vs. pathological staging

A

How extensive is the cancer?

  • TMN system
  • other factors –> tumor markers
  • therapy is stage directed but not mandated
  • staging systems do not incorporate all known variables –> therefore, therapy is determined by stage in addition to other factors (physiology, patient preferences, local expertise)
  • staging does not incorporate performance status

Clinical vs. pathological staging

  • clinical stage = stage determined after complete clinical assessment (physical exam, laboratory, radiologic, biopsy, mediastinoscopy, etc.) –> clinical stage frequently underestimates the extent of disease
  • pathological stage = stage determined after resection (or attempted resection) OR pathological determination of metastatic disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Tumor board

A

Organized meeting of internal medicine, surgical, and radiation oncologists –> include radiologists and pathologists

  • review all evidence and assign clinical and/or pathologic stage
  • recommend treatment approaches
  • OK to use staging manuals –> guidelines change frequently
  • important to have in mid the clear staging criteria for curative intent in each tumor type
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Performance status

A

Considers the general ability of a patient to do things –> 2 major scales

  1. Karnofsky –> percentage score, more detailed
  2. Eastern Cooperative Oncology Group
    - -> 0 = no limitations
    - -> 1 = OOB all day, capable of a full day of work
    - -> 2 = OOB > 50% of the day, limited ability to work
    - -> 3 = OOB < 50% of day –> capable of self care
    - -> 4 = requires nursing assistance with ADL
    - ->5 = dead
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How is staging accomplished?

A
  • History and physical
  • Radiographic studies
  • Laboratory evaluation
  • Invasive and surgical
  • Clinical vs. surgical staging
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Radiographic studies in cancer diagnosis

A
  1. Plain films = chest X ray –> easy, inexpensive, useful for initial assessment and follow up
  2. CT = best method for many disease –> excellent imaging of most organs
    - need IV contrast (iodinated) for best assessment usually
    - easy and relatively inexpensive
  3. MRI = best method for imaging the brain and spinal cord
    - useful in certain special situation in chest and liver
    - cannot use in patients with ferrous metals in the body
    - slightly more difficult to obtain and more expensive than CT
  4. PET scans = assessment of undiagnosed masses to determine malignant potential
    - useful as part of staging evaluation for lung and other cancers
    - requires 18FluoroDeoxyGlucose isotope
    - expensive, limited availability
    - may ultimately prove valuable in follow up
    - currently overutilized –> PET avidity and value in each cancer has yet to be established
  5. PET/CT
  6. Ultrasound
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Surgical staging

A

Occurs prior to definitive procedure

  • provides information regarding lymph node status (primarily in lung cancer)
  • mediastinoscopy
  • other methods are gaining favor –> e.g. endoscopic bronchial ultrasound
17
Q

Treatment of cancer

A

Stage directed

Goals of therapy –> vary depending upon disease, extent, and patient

For solid tumors –> must control both the local disease (i.e. primary disease) and the systemic disease

Local therapy for local disease:

  • surgery
  • radiation
  • adjuvant therapy
  • others –> radiofrequency ablation, cryotherapy

Locally advanced disease –> combined modality therapy

Advanced disease:

  • chemotherapy
  • hormonal therapy –> breast/prostate cancer
  • immunotherapy
18
Q

Stage directed therapy –> localized disease

A

Confined to tissue or origin, no invasion of adjacent structures, at most local lymph node

  • treat with localized therapy –> surgery or radiation
  • adjuvant chemotherapy
19
Q

Stage directed therapy –> locally advanced disease

A

Regional lymph node involvement, large tumors, invades adjacent structures
- treat with combined modality therapy –> chemotherapy, radiation, surgery

20
Q

Stage directed therapy –> advanced diseases = metastases

A

Distant spread

  • treat with systemic therapy –> chemo, hormonal
  • radiation + surgery to relive/prevent specific local complications, occasionally to remove residual disease for cure (e.g. testicular cancer)
21
Q

Surgical treatment

A

Can you operate vs. should you operate

Various goals of surgery:

  • diagnostic
  • curative
  • staging procedures –> e.g. mediastinoscopy
  • “debulking” to optimize use of other treatments
  • palliative –> treatment and prevention of complications

For cure, goal should be complete removal of the tumor with clear margins in an anatomically appropriate fashion
- potentially curative procedure should not be undertaken until after completion of non-surgical staging

Resectable vs. operable

22
Q

Principles of radiation therapy

A

Maximize dose to the target (tumor or areas at risk) while minimizing exposure to normal cells

  • precise target localization
  • reliable target immobilization
  • conformal treatment delivery

Use a fractionated dose that causes lethal damage to cancer cells but only sublethal damage to nearby normal cell populations

23
Q

Radiation biology

A

Photons

  • gamma rays = photons produced from radiation decay –> cobalt-60, cesium-137, iridium-192, etc.
  • X-rays = man made
  • –> diagnostic radiology = kilovoltage energy
  • –> radiation oncology = megavoltage energy

Electrons, protons, neutrons, etc

24
Q

Radiation dose

A

Uses radiation of a certain type (ionizing) to cause tissue damage by ions release from target molecules and from DNA
- gray = gy: a unit of energy delivered per mass of tissue (cGy = 1 rad)

Fractionated dosing:

  • 1.25 - 8 Gy daily fraction x a total dose dictated by organ tolerance
  • 1.8 - 2 Gy for curative cases
  • palliative cases usually 3 gy per day –> can be 8 Gy for those with very poor performance status

Total dose = a complex balance between giving enough radiation to kill the primary and subclinical tumor and avoiding normal tissues

  • stage I seminoma: 25 Gy in 1.25 Gy fxn
  • high risk prostate cancer: 75.6-84.4 Gy
25
Q

Systemic cancer treatment = chemotherapy/biological therapy

A

Chemotherapy:

  • cytotoxic “small molecule” drugs
  • targeted “small molecule”

Biological therapy:

  • antibodies/antibody drug complexes
  • ligand directed proteins
  • cytokines
  • cellular therapies
  • gene therapies
26
Q

Principles of chemotherapy

A
  • drug sensitivity is specific to disease
  • log-kill hypothesis = fractional kill
  • growth kinetics –> small tumors are more sensitive to chemo
  • overlapping toxicities are additive
  • cytotoxicity is usually dose dependent
27
Q

Combination chemotherapy principles

A
  • individual drugs should be effective
  • combinations should “make sense” –> be synergistic, etc.
  • repeated dosing > single high doses
  • low stage disease responds better
  • avoid cross resistant combinations
  • toxicities should not overlap
  • use each drug at optimum dose
28
Q

Utilization of antineoplastic agents

A

Increase life expectancy/palliative treatment in advanced disease –> breast, colon, lung, prostate, bladder, pancreas

Curative therapy of advanced disease

  • hematologic malignancies –> hodgkins, NHL, acute myelogenous leukemia, acute lymphoblastic leukemia
  • solid tumors –> testicular cancer + choriocarcinoma

Chemoradiotherapy for curative treatment of locally advanced disease –> bulky hodgkins, stage III NSCLC, limited SCLC, rectal cancer

Preservation of organ function –> laryngeal cancer, lung cancer, anal carcinoma

Adjuvant therapy in early stage disease –> breast, colon, lung, prostate, bladder

29
Q

The decision to use chemotherapy

A
  • should be evidence based
  • drug/regiment to be utilized should be employed in a patient who could have been enroled in a trial which demonstrated a positive outcome for that particular treatment plan
  • decisions require that the patient be carefully staged
30
Q

Stage I and II disease - the decision to utilize adjuvant chemotherapy

A

Adjuvant treatment: therapy administered after all known disease is removed because there is a statistical possibility of relapse

  • requires large studies to prove benefit
  • must balance the risks of exposing cured patients to potentially toxic agents
  • proven benefit in all major solid tumors –> lung, breast, colon, prostate
31
Q

Decision to use chemo as part of multimodality treatment

A

Locally advanced disease is frequently unresectable or has poor long term outcome due to both local and systemic relapse

  • chemo can improve the outcomes of radiotherapy
  • risk of increased toxicity
32
Q

Decision to utilize chemo in advanced cancer

A

With a few notable exceptions, most metastatic cancers are incurable

  • chemo can improve both quality and quantity of life in many patients
  • factors beyond classic staging frequently come into play –> performance status, co-morbidities, patient attitude
33
Q

Future of chemotherapy

A

Improved understanding of the molecular basis of cancer will lead to better therapy –> “targeted agents”

  • more narrowly targeted agents will result in fewer side effects
  • patient selection –> prognostic and predictive markers
34
Q

Individualization of therapy

A

Not a new concept –> we have individualized based upon patient factors including performance status, organ function, toxicity, etc. for a long time

New examples:

  • Bcr-abl –> imatinib
  • ER –> tamoxifen
  • Her2-neu –> trasztusumab, lapatanib
  • RAR alpha –> all trans retinoic acid
  • Ras mutation –> cetuximab
35
Q

Prognostic vs. predictive

A

Prognostic –> marker that indicates how the patient will do irrespective of therapy (unless specifically directed)

Predictive –> marker that indicates how a patient will respond to treatment

Examples:

  • ER is a positive prognostic and positive predictive marker (tamoxifen) in breast cancer
  • Her 2-neu is a negative prognostic and positive predictive marker (trastuzumab) in breast cancer
  • Ras is a negative prognostic and negative predictive marker (cetuximab) in colon cancer
  • ERCC1 is a positive prognostic and negative predictive (cisplatin) marker in lung cancer
36
Q

Important points of lecture

A
  • Cancer can present in a myriad of ways.
  • Symptoms can be a direct or indirect effect of the malignancy.
  • Screening for asymptomatic disease has been demonstrated to improve survival in some cancers.
  • Diagnosis requires tissue.
  • Staging is the extent of the cancer and is based upon history, exam, labs and radiologic studies (depending upon the malignancy).
  • Treatment is stage directed